Cardiff Lexington Joins OTCQX Market
Analysis based on 6 articles · First reported Apr 09, 2026 · Last updated Apr 09, 2026
The upgrade of Cardiff Lexington Corporation to the OTCQX Best Market is expected to increase its visibility and engagement with U.S. investors, potentially leading to increased trading activity and shareholder value. For OTC Markets Group Inc., this event signifies the continued growth and credibility of its regulated markets, attracting more companies and investors.
Cardiff Lexington Corporation, a publicly traded healthcare services holding company, has qualified to trade on the OTCQX Best Market, operated by OTC Markets Group Inc. This move, effective April 9, 2026, represents an upgrade from the OTCQB Venture Market. Alex Cunningham, CEO of Cardiff Lexington Corporation, stated that this is a crucial step towards listing on a major U.S. exchange, aiming to enhance financial disclosure, corporate governance, and investor engagement. Cardiff Lexington Corporation focuses on orthopedic, spine, and pain management platforms through subsidiaries like Nova Ortho and Spine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard